Fractional Laser Therapy and Dermabrasion for Scar Revision

This study has been withdrawn prior to enrollment.
(PI has left University of Minnesota. Study was complete.)
Sponsor:
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01409863
First received: August 2, 2011
Last updated: August 3, 2011
Last verified: August 2011
  Purpose

Post traumatic and post surgical scar resurfacing is a common reason for patient visits to dermatologists and plastic surgeons. The Fraxel Laser is a new FDA cleared treatment for textural irregularities of the skin. There have been no studies examining the efficacy of Fraxel specifically for scar resurfacing though it is being used in clinical practice as its clearance was given under hte umbrella of "coagulation of soft tissue." Dermabrasion is the gold standard for scar resurfacing and provides the criterion against which Fraxel therapy should be measured. The goals of this study will be to compare the safety and efficacy of fractional photothermolysis (Fraxel) with dermabrasion when used for scar revision.


Condition Intervention
Scar
Procedure: laser and standard diamond fraise dermabrasion

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Comparison Evaluation of Fractional Laser Therapy an Dermabrasion for Scar Revision

Resource links provided by NLM:


Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Enrollment: 6
Study Start Date: March 2010
Intervention Details:
    Procedure: laser and standard diamond fraise dermabrasion
    standard dermabrasion, CO2 laser resurfacing
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • post surgical or post traumatic scar on face or scalp
  • age 18 or older
  • able to read and comprehend English
  • Willing to follow treatment schedule and post treatment care requirements
  • signed informed consent form
  • Fitzpatrick skin type I-III

Exclusion Criteria:

  • known photosensitivity
  • taken any medications known to induce photosensitivity in previous three months
  • taken accutane within past 12 months
  • pregnant or nursing
  • currently on topical or oral antibiotics
  • immunocompromised status
  • skin type IV or greater
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01409863

Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: John Christophel, MD University of Minnesota - Clinical and Translational Science Institute
  More Information

No publications provided

Responsible Party: John J Christophel, University of Minnesota
ClinicalTrials.gov Identifier: NCT01409863     History of Changes
Other Study ID Numbers: 1001M75732
Study First Received: August 2, 2011
Last Updated: August 3, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
post surgical or post traumatic scar on face or scalp

Additional relevant MeSH terms:
Cicatrix
Fibrosis
Pathologic Processes

ClinicalTrials.gov processed this record on April 23, 2014